◆ 会议时间：2024年5月7-11日
◆ 会议地点：美国 巴尔的摩

◆ 会议简介：

2024年第27届美国基因与细胞治疗学会(ASGCT)年会将于2024年5月7日至11日在美国巴尔的摩举行。ASGCT年会是全球基因和细胞治疗领域规模最大的学术会议，为与会者提供了一个介绍最新基因与细胞疗法的发展以及提出并进行批判性讨论的国际平台。作为全球领先的基因与细胞治疗学会议，ASGCT年会吸引了近3500名来自世界各地的专业人士与会，与会者包括科学家、医生、患者和支持者等等（2021年虚拟会议有近6800余名代表参与）。

美国基因与细胞治疗学会(ASGCT)成立于1996年，是全球最大的专业从事基因和细胞治疗研究的非赢利性医学组织，是世界基因与细胞治疗领域最具权威性与公信力的机构，在全球拥有超过2500名成员。ASGCT宣设有癌症治疗、心血管和遗传委员会等若干个科学委员会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

ASGCT 2024 - 27th Annual Meeting of the American Society of Gene & Cell Therapy

Date:　May 7-11, 2024
Venue: Baltimore Convention Center, Baltimore, MD, USA

摘要征文投稿：

IMPORTANT DATES

点此提交摘要>>>Submit Abstract>>>

GENERAL REQUIREMENTS

• All abstracts must be submitted in clear and concise English. Spelling may be in US English or UK English.
• In most cases, Greek letters and other special characters will transfer from your word processing software via copy and paste functions.
• Remove all track changes before submitting your abstract; these changes can be picked up with copy and paste functions, making the abstract incoherent.
• The title should be entered exactly as it is to appear online—titles should be submitted in title case.
• The names of all co-authors and their institutional affiliations must be provided at time of submission.
  • Any names excluded in submission will not be listed in the author block of the publication online or in the Journal.
• It is the responsibility of the submitter to proofread the abstract and author list carefully.
• Tables and figures may be uploaded via a photo file type.
• The abstract may be structured (ie. divided into sections: introduction, methods, results, conclusions) or unstructured.
• Do not use bold type or underline formatting—italic type is acceptable.
• Changes to abstracts may be made by the submitter prior to the close of the submission deadline.
  • Changes after the submission deadline but before the review has started must be sent to abstracts@asgct.org—all changes should include the tracking number and title of the abstract and explicitly say what changes need to be made. New authors must be listed in order and with their institutions, locations, and email addresses.
  • No changes will be made to any abstract or author block after Review has started on Feb. 1, 2024. 

The presenting author of abstracts selected for oral or poster presentation must attend the Annual Meeting in person. If the original designated presenting author cannot attend, a co-author may be designated as an alternative presenter.

注册费：

All rates are valid for in-person and virtual attendance.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。